Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Dr. Dawn Hershman Receives the 2020 Hologic Women Who Conquer Cancer Mentorship Award

Dr. Dawn Hershman Receives the 2020 Hologic Women Who Conquer Cancer Mentorship Award

Dr. Dawn Hershman of the Herbert Irving Comprehensive Cancer Center at Columbia University received the "2020 Hologic, Inc Endowed Women Who Conquer Cancer Mentorship" award. This award is given to women leaders who have carried out outstanding work in oncology.

Hologic, Inc. is a medical technology company focused primarily on women’s health. It sells medical devices for diagnostics, surgery and medical imaging. In particular, it has many FDA-approved tests and devices in the field of breast cancer (see the company’s production history). In March 2020, its recently developed coronavirus test received emergency use authorization from the FDA.

In her interview, Dr. Hershman said, "Over time, I have learned about leadership from many people I admire." She added, “I pay attention to people I think are good and try to adopt their qualities.”

Hershman leads the Breast Cancer Program at her institution. Although her clinical and research priorities focus on breast cancer, one of the underlying aims of her work has been to find ways to improve cancer outcomes by identifying factors associated with inadequate cancer treatment and testing interventions that can make a difference.

To achieve this, she collaborates with a team of researchers specializing in different fields to conduct observational research and turn findings into interventions intended to improve the quality of many cancer treatments.

Hershman said, “I am very proud that I have been able to bring together many people from different fields and do work that makes a difference in people’s lives”.

RELATED TOPICS

Mentoring to Reduce Gender Inequalities in Oncology

This award highlights the work of women mentors in oncology. It aims to reduce gender inequality in careers through mentoring and professional development.

In 2016, the women’s committee of the European medical oncology society conducted a survey of male and female oncologists in Europe and abroad. Of the 462 oncologists surveyed, 76.7% were women. Among women, 45.5% had held a leadership role, compared with 65.0% of male respondents; in other words, women were less likely to hold leadership positions in oncology. Other results showed that men were more likely to hold leadership roles even in clinical teams where women took on more responsibilities. Women were also more likely to believe that their gender affected their careers.

Although the world seems to have made progress on this issue (14.4% of women surveyed believed there had been substantial progress toward closing the gender gap), there is still much work to do.

Hershman said, “There is no doubt that everyone faces a number of obstacles on the path to academic success, but these obstacles affect women more than men.”

Of the women oncologists who took part in the 2016 survey, 64.2% said the greatest challenge for women’s career development was the balance between work and family. Dr. Hershman shares this view. She adds that traveling to meetings, relocating to find job opportunities and other factors highlight the inequality between women and men in oncology.

Dr. Hershman offers women oncologists advice on raising awareness and helping to reduce these inequalities: “Knowing the barriers, guiding students, taking initiatives in the promotion process and serving on committees help reduce inequality in leadership in oncology.”

Sources

Dr. Dawn Hershman Honored With the 2020 Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award.
dailynews.ascopubs.org - 6 May 2020.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Dr. Dawn Hershman Receives the 2020 Hologic Women Who Conquer Cancer Mentorship Award

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy